The effect of rasagiline on cognition in Parkinson's disease.
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2015
At a glance
- Drugs Rasagiline (Primary)
- Indications Cognition disorders; Parkinson's disease
- Focus Therapeutic Use
- 03 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Jun 2011 New trial record